Selected article for: "demyelinating disease and human demyelinating"

Title: In vivo analysis of glial cell phenotypes during a viral demyelinating disease in mice
  • Document date: 1989_11_1
  • ID: 4t98bah8_1
    Snippet: (1 WPI) and were the only immunostained cells labeled at that time by a 2-h in vivo pulse of tritiated thymidine. Both GFAP+ only and GFAP+, 04+ astrocytes were also increased in the spinal cord at 1 WPI. Between two and four WPI, the infected spinal cord was characterized by the loss of (CNP+, 04+) oligodendrocytes within demyelinating lesions and the presence of O-2A progenitor cells and 04+, GFAP+ astrocytes, both of which could be labeled wit.....
    Document: (1 WPI) and were the only immunostained cells labeled at that time by a 2-h in vivo pulse of tritiated thymidine. Both GFAP+ only and GFAP+, 04+ astrocytes were also increased in the spinal cord at 1 WPI. Between two and four WPI, the infected spinal cord was characterized by the loss of (CNP+, 04+) oligodendrocytes within demyelinating lesions and the presence of O-2A progenitor cells and 04+, GFAP+ astrocytes, both of which could be labeled with thymidine. As remyelination proceeded, CNP immunostaining returned to near normal and tritiated thymidine injected previously during the demyelinating phase now appeared in CNP+ oligodendrocytes. Thus 04 positive O-2A progenitor cells proliferate early in the course of the demyelinating disease, while CNP positive oligodendrocytes do not. The timing of events suggests that the O-2A progenitors may give rise to new oligodendrocytes and to type 2 astrocytes, both of which are likely to be instrumental in the remyelination process. I s small rodents, regeneration of central nervous system (CNS) ~ myelin is often efficient after a demyelinating episode (reviewed in Ludwin, 1981) . In contrast, in multiple sclerosis, the paradigm of demyelinating diseases in human CNS, remyelination is often insufficient (reviewed in Silberberg, 1986) . Thus it appears important to elucidate the exact cellular and molecular events underlying CNS remyelination.

    Search related documents:
    Co phrase search for related documents
    • central nervous system and CNS central nervous system regeneration: 1, 2, 3
    • central nervous system and cns remyelination: 1, 2, 3, 4, 5, 6
    • central nervous system and demyelinating disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • central nervous system and demyelinating disease course: 1, 2
    • central nervous system and demyelinating phase: 1, 2
    • central nervous system and early proliferate: 1
    • central nervous system and event timing: 1
    • central nervous system and human cns: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • CNS central nervous system and demyelinating disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • CNS central nervous system and demyelinating disease course: 1
    • CNS central nervous system and demyelinating phase: 1
    • CNS central nervous system and human cns: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cns remyelination and demyelinating disease: 1, 2, 3, 4
    • cns remyelination and early proliferate: 1
    • cns remyelination and human cns: 1, 2, 3, 4
    • demyelinating disease and early proliferate: 1
    • demyelinating disease and event timing: 1
    • demyelinating disease and human cns: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • demyelinating disease course and early proliferate: 1